Virtu Financial’s CureVac CVAC Stock Holding History

Virtu Financial’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,709	Closed	-$48K	–	1745
2025 Q4	$48K	Buy	+10,709	New	+$54.9K	﹤0.01%	1308
2024 Q1	–	Sell	-37,611	Closed	-$158K	–	1529
2023 Q4	$158K	Buy	+37,611	New	+$204K	0.01%	910
2023 Q3	–	Sell	-10,648	Closed	-$111K	–	1418
2023 Q2	$111K	Buy	+10,648	New	+$95.2K	0.01%	1012
2021 Q4	–	Sell	-10,400	Closed	-$568K	–	1797
2021 Q3	$568K	Sell	10,400 -10,262	-50%	-$618K	0.05%	406
2021 Q2	$1.52M	Buy	+20,662	New	+$2.07M	0.15%	112
2021 Q1	–	Sell	-12,018	Closed	-$974K	–	1665
2020 Q4	$974K	Buy	+12,018	New	+$920K	0.11%	233

Virtu Financial's CVAC Position: Q1 2026 in Review

Virtu Financial sold out of CureVac (CVAC) in Q1 2026, closing a stake of 10,709 shares — an estimated $48K sold.

Virtu Financial first reported a position in CVAC in Q4 2020 and held it in 6 quarters. The position peaked at $1.52M in Q2 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Virtu Financial reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 10,709 CureVac shares in Q1 2026, an estimated $48K.
Virtu Financial first reported a position in CureVac in Q4 2020 and held it in 6 quarters.
Virtu Financial's CureVac position peaked at $1.52M in Q2 2021.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.